No Data
No Data
Sera Prognostics Highlights PreTRM at Healthcare Conference
Sera Prognostics Advances Maternal Health Research Initiatives
With 40% Stake, Sera Prognostics, Inc. (NASDAQ:SERA) Seems to Have Captured Institutional Investors' Interest
Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting
Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Have Sera Prognostics Insiders Been Selling Stock?
全力買い : Do you have bio recommendations?
70927684 : DO IT!!!
70927684 : Let's Go Fuckers!!! Get Ya SOME!!!